nach oben

Erschienen in:

17.05.2022 | Multicenter Seminars: IBD (MUSE: IBD)

Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy—Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring

verfasst von: Zoë S. Gottlieb, Michael Dolinger, Maia Kayal, Bhavana Bhagya Rao, Abhik Bhattacharya, Marla C. Dubinsky, Ryan C. Ungaro

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Excerpt

A 36-year-old woman with a history of pan-ulcerative colitis (UC) complicated by erythema nodosum presented at 14 weeks gestation following successful in vitro fertilization (IVF) with several months of increased stool frequency, urgency, and bleeding. …

Mahadevan U et al. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American gastroenterological association IBD Parenthood project working group. Am J Obstet Gynecol 2019;220:308–323.CrossRef

McConnell RA, Mahadevan U. Pregnancy and the patient with inflammatory bowel disease: fertility, treatment, delivery, and complications. Gastroenterol Clin N Am 2016;45:285–301.CrossRef

Abhyankar A, Ham M, Moss AC. Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013;38:460–466.CrossRef

Torgersen KL, Curran CA. A systematic approach to the physiologic adaptations of pregnancy. Crit Care Nurs Q 2006;29:2–19.CrossRef

Klajnbard A et al. Laboratory reference intervals during pregnancy, delivery and the early postpartum period. Clin Chem Lab Med 2010;48:237–248.CrossRef

Larsson A et al. Reference values for clinical chemistry tests during normal pregnancy. BJOG 2008;115:874–881.CrossRef

Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 2009;114:1326–1331.CrossRef

Tandon P et al. Noninvasive methods for assessing inflammatory bowel disease activity in pregnancy: a systematic review. J Clin Gastroenterol 2019;53:574–581.CrossRef

Gottlieb ZS, O-Hara S, Riggs AR, Monroe J, Mella MT, Dubinsky MC. Trends in common laboratory markers during pregnancy in women with quiescent IBD. Gastroenterology 2020;158:S-447.

10.

Kammerlander H et al. Fecal calprotectin during pregnancy in women with moderate-severe inflammatory bowel disease. Inflamm Bowel Dis 2018;24:839–848.CrossRef

11.

Allocca M et al. Point-of-care ultrasound in inflammatory bowel disease. J Crohns Colitis 2021;15:143–151.CrossRef

12.

De Voogd F, et al. Intestinal ultrasound to evaluate treatment response during pregnancy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2021.

13.

Flanagan E et al. Monitoring inflammatory bowel disease in pregnancy using gastrointestinal ultrasonography. J Crohns Colitis 2020;14:1405–1412.CrossRef

14.

Papamichael K et al. Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases. Expert Rev Clin Immunol 2019;15:837–848.CrossRef

15.

Papamichael K et al. Infliximab concentration thresholds during induction therapy are associated with short-term mucosal healing in patients with ulcerative colitis. Clin Gastroenterol Hepatol 2016;14:543–549.CrossRef

16.

Papamichael K et al. Therapeutic drug monitoring during induction of anti-tumor necrosis factor therapy in inflammatory bowel disease: defining a therapeutic drug window. Inflamm Bowel Dis 2017;23:1510–1515.CrossRef

17.

Dubinsky MC et al. Dashboard-driven accelerated infliximab induction dosing increases infliximab durability and reduces immunogenicity. Inflamm Bowel Dis. 2022.

18.

Seow CH et al. The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease. Aliment Pharmacol Ther 2017;45:1329–1338.CrossRef

Titel: Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy—Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring
verfasst von: Zoë S. Gottlieb
Michael Dolinger
Maia Kayal
Bhavana Bhagya Rao
Abhik Bhattacharya
Marla C. Dubinsky
Ryan C. Ungaro
Publikationsdatum: 17.05.2022
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 8/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-022-07532-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy—Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2022

Breastfeeding in Prevention of Postpartum Acute Pancreatitis

De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease

Kimura–Takemoto Classification: A Tool to Predict Gastric Intestinal Metaplasia Progression to Advanced Gastric Neoplasia

Comorbidities Associated with Worse Outcomes Among Inpatients Admitted for Acute Gastrointestinal Bleeding

Endobiliary Radiofrequency Ablation Using a Short-Type Balloon Enteroscope in Patients with Surgically Altered Anatomy

Antibacterial and Immunosuppressive Effects of OPS-2071, a Candidate Therapy for Inflammatory Bowel Disease

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin